« With 50 years of Servier’s presence in Belgium and 40 years in Luxembourg, I have the privilege of leading a dynamic team with a high level of expertise, committed to patients and healthcare professionals. »
Pierre Boyer, General Manager Servier BeLux
countries in which
the Group’s medicines
of revenue from brand-name
medicines invested in R&D in 2019/2020.
euros in revenue in 2019/2020 comprising €3,3 billion for
brand-name medicines and
€1,4 billion for generic medicines.
4 therapeutic areas
oncology, immuno-inflammation, cardiometabolism,
Servier Medical Art is a medical image bank that we make available to illustrate your medical communications.